Challenges in Diagnosis and Treatment of Fasciola hepatica Infection.
Fatihan PınarlıkŞiran Keskeİzzet RozanesÖnder ErgönülPublished in: Infectious diseases & clinical microbiology (2023)
A 57-year-old female patient presented with fever, nausea, vomiting, loss of appetite, and weight loss within the last two months. Ceftriaxone and metronidazole therapy was started upon discovery of a liver abscess but provided no benefit. Following the of abscess biopsy, the patient developed fever, itching, anemia, acute renal failure, hyperbilirubinemia, and eosinophilia that required intensive care unit (ICU) admission. The Fasciola hepatica antibodies were detected by enzyme-linked immunosorbent assay (ELISA). Triclabendazole was started, after which the symptoms and magnetic resonance imaging (MRI) findings regressed. Even without eosinophilia, F. hepatica should be considered in cases with a liver abscess that does not respond to antibiotics.
Keyphrases
- intensive care unit
- magnetic resonance imaging
- weight loss
- case report
- contrast enhanced
- high throughput
- bariatric surgery
- rare case
- mechanical ventilation
- chemotherapy induced
- emergency department
- computed tomography
- liver failure
- small molecule
- chronic kidney disease
- roux en y gastric bypass
- respiratory failure
- stem cells
- drug induced
- ultrasound guided
- type diabetes
- adipose tissue
- metabolic syndrome
- gastric bypass
- depressive symptoms
- body mass index
- body weight
- mesenchymal stem cells
- extracorporeal membrane oxygenation
- sleep quality
- iron deficiency
- glycemic control